ARQT icon

Arcutis Biotherapeutics
ARQT

50 hedge funds and large institutions have $974M invested in Arcutis Biotherapeutics in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$314M
2
+$170M
3
+$139M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$119M
5
VC
Vivo Capital
California
+$50.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$610K
27
$594K
28
$477K
29
$471K
30
$354K
31
$294K
32
$230K
33
$224K
34
$193K
35
$184K
36
$159K
37
$139K
38
$113K
39
$110K
40
$109K
41
$100K
42
$90K
43
$80K
44
$48K
45
$43K
46
$38K
47
$27K
48
$16K
49
$12K
1
2